Core Scientific, Inc./tx (CORZW) stock
CORZWNasdaqFinance ServicesFiscal year ends December 31Also trades as CORZ, CORZR, CORZZ
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 2/30223% above fair value
$6.54−1.23 (-15.83%)
Close on Oct 30, 2026Market cap $4.26BP/E –Yield –
Core Scientific ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Core Scientific's ebitda for the twelve months ending Jun 30, 2026 was -$498.59M. For fiscal 2025 it was -$176.68M. The highest annual figure on record is $164.86M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$176.68M | – |
| FY2024 | Dec 31, 2024 | -$28.86M | -127.5% |
| FY2023 | Dec 31, 2023 | $104.96M | – |
| FY2022 | Dec 31, 2022 | -$1.88B | -1243.0% |
| FY2021 | Dec 31, 2021 | $164.86M | +5259.4% |
| FY2020 | Dec 31, 2020 | $3.08M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$62.97M | – |
| Q1 FY2026 | Mar 31, 2026 | -$293.77M | – |
| Q4 FY2025 | Dec 31, 2025 | -$103.38M | – |
| Q3 FY2025 | Sep 30, 2025 | -$38.46M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.53M | – |
| Q1 FY2025 | Mar 31, 2025 | -$27.31M | -132.4% |
| Q4 FY2024 | Dec 31, 2024 | -$39.35M | -212.0% |
| Q3 FY2024 | Sep 30, 2024 | -$12.53M | -202.8% |
| Q2 FY2024 | Jun 30, 2024 | -$61.21M | -304.4% |
| Q1 FY2024 | Mar 31, 2024 | $84.22M | +204.1% |
| Q4 FY2023 | Dec 31, 2023 | $35.14M | – |
| Q3 FY2023 | Sep 30, 2023 | $12.19M | – |
| Q2 FY2023 | Jun 30, 2023 | $29.94M | – |
| Q1 FY2023 | Mar 31, 2023 | $27.70M | +79.6% |
| Q4 FY2022 | Dec 31, 2022 | -$567.36M | -562.6% |
| Q3 FY2022 | Sep 30, 2022 | -$336.80M | -2983.8% |
| Q2 FY2022 | Jun 30, 2022 | -$995.55M | -5452.1% |
| Q1 FY2022 | Mar 31, 2022 | $15.42M | +29.1% |
| Q4 FY2021 | Dec 31, 2021 | $122.63M | – |
| Q3 FY2021 | Sep 30, 2021 | $11.68M | – |
| Q2 FY2021 | Jun 30, 2021 | $18.60M | – |
| Q1 FY2021 | Mar 31, 2021 | $11.94M | – |